Skip to main content

Table 3 Comparisons of the effects of the MILK and NCEP diets on the different cardiometabolic risk factors

From: Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity

Variables

MILK

NCEP

P between

Pre

Post

%

P within

Pre

Post

%

P within

Body weight (kg)

82.6 ± 10.3

81.9 ± 10.4

−0.8%

0.003

82.8 ± 10.5

81.5 ± 10.4

−1.6%

<0.001

0.007

Waist circumference (cm)

102.7 ± 8.4

102.8 ± 7.9

0.1%

0.92

104.0 ± 9.0

101.8 ± 8.3

−2.1%

0.004

0.03

Body mass index (kg/m 2 )

31.7 ± 3.3

31.4 ± 3.4

−0.8%

0.001

31.7 ± 3.5

31.2 ± 3.4

−1.6%

<0.001

0.007

Total cholesterol (mmol/L)

5.75 ± 0.84

5.60 ± 0.87

−2.6%

0.39

5.87 ± 0.78

5.53 ± 0.76

−5.8%

<0.001

0.01

VLDL cholesterol (mmol/L) a

0.55 ± 0.48

0.58 ± 0.43

5.3%

0.78

0.51 ± 0.32

0.47 ± 0.37

−7.9%

0.64

0.57

LDL cholesterol (mmol/L)

3.94 ± 0.55

3.97 ± 0.78

0.8%

0.96

4.11 ± 0.71

3.98 ± 0.71

−3.0%

0.36

0.42

HDL cholesterol (mmol/L)

1.27 ± 0.25

1.06 ± 0.19

−16.2%

<0.001

1.26 ± 0.20

1.08 ± 0.19

−14.1%

<0.001

0.29

Total/HDL cholesterol ratio

4.68 ± 1.10

5.42 ± 1.23

15.9%

<0.001

4.81 ± 1.12

5.28 ± 1.24

9.9%

<0.001

0.26

Triglycerides (mmol/L) a

1.84 ± 0.86

1.87 ± 0.92

1.9%

0.77

1.78 ± 0.75

1.60 ± 0.78

−10.2%

0.14

0.14

VLDL triglycerides (mmol/L) a

1.35 ± 0.78

1.40 ± 0.85

3.5%

0.64

1.29 ± 0.69

1.16 ± 0.73

−9.8%

0.25

0.18

LDL size (Å)

256.4 ± 2.8

256.3 ± 2.4

0.0%

0.64

256.1 ± 2.9

256.2 ± 2.6

0.0%

0.74

0.59

LDL-PPD (Å)

255.6 ± 2.9

255.3 ± 2.7

−0.1%

0.45

255.2 ± 3.0

255.5 ± 3.0

0.1%

0.59

0.27

Apo A-I (g/L)

1.52 ± 0.18

1.40 ± 0.16

−7.9%

<0.001

1.55 ± 0.17

1.36 ± 0.18

−12.1%

<0.001

0.06

Apo B (g/L)

1.11 ± 0.21

1.10 ± 0.22

−1.6%

0.29

1.13 ± 0.19

1.07 ± 0.18

−4.8%

0.02

0.37

VLDL apo B (g/L)

0.16 ± 0.08

0.16 ± 0.08

−0.5%

0.94

0.14 ± 0.06

0.13 ± 0.07

−7.2%

0.36

0.42

LDL apo B (g/L)

0.96 ± 0.15

0.94 ± 0.19

−1.8%

0.32

0.98 ± 0.17

0.94 ± 0.15

−4.4%

0.06

0.53

CRP (mg/L)

2.94 ± 1.80

3.19 ± 2.30

8.5%

0.40

3.38 ± 2.49

3.09 ± 2.33

−8.8%

0.21

0.15

Adiponectine (mmol/L)

10.52 ± 4.31

9.36 ± 4.26

−11.1%

0.01

10.80 ± 4.47

9.36 ± 4.09

−13.3%

0.001

0.58

Endothelin (pg/mL)

0.65 ± 0.25

0.57 ± 0.30

−11.5%

0.003

0.66 ± 0.35

0.55 ± 0.23

−17.6%

0.001

0.85

VCAM-1 (ng/mL)

nd

655.2 ± 179.4

  

nd

690.7 ± 184.5

−5.1%

 

0.25

ICAM-1 (ng/mL)

nd

203.8 ± 48.8

  

nd

193.9 ± 32.6

5.1%

 

0.22

E-selectin (ng/mL)

nd

32.8 ± 15.3

  

nd

30.5 ± 12.3

7.5%

 

0.51

  1. Values are shown as mean ± SD.
  2. aValues were log-transformed before statistical analyses.
  3. Diet specific baseline values and changes in waist circumference were included as covariates in all models, except when outcomes were measured only post diet, in which case post diet waist circumference was included as a covariate. Change in waist circumference was also not included as a covariate when analysing this particular outcome. PPD: peak particle diameter, Apo: apolipoprotein, CRP: C-reactive protein, VCAM-1: vascular cell adhesion molecule 1, ICAM-1: Intercellular adhesion molecule 1, nd: not determined.